Department of Chemistry, Sri Venkateswara University, Tirupati, Andhra Pradesh, India.
Arch Pharm (Weinheim). 2021 Aug;354(8):e2000483. doi: 10.1002/ardp.202000483. Epub 2021 May 11.
A library of bis(azolyl)sulfonamidoacetamides was prepared by the reaction of azolylsulfonylamines with azolylchloroacetamides in the presence of pyridine/4-(dimethylamino)pyridine (DMAP) under ultrasonication. The reaction proceeded well with DMAP, resulting in a higher yield of the products. The antimicrobial activity of the compounds indicated that N-{5-[N-(2-{[4-(4-chloro-1H-pyrrol-2-yl)-1H-imidazol-2-yl)amino}-2-oxoethyl)sulfamoyl]-4-phenylthiazol-2-yl}benzamide (22a), N-{5-[N-(2-{[4-(4-chloro-1H-pyrrol-2-yl)-1H-imidazol-2-yl]amino}-2-oxoethyl)sulfamoyl]-4-(4-chlorophenyl)thiazol-2-yl}benzamide (22c), and N-{5-[N-(2-{[4-(4-chloro-1H-pyrrol-2-yl)-1H-imidazol-2-yl]amino}-2-oxoethyl)sulfamoyl]-4-(4-chloro-phenyl)-1H-imidazol-2-yl}benzamide (24c) exhibited a low minimal inhibitory concentration (MIC) against Bacillus subtilis, equal to the standard drug, chloramphenicol. Compounds 22c and 24c also showed low MICs against Aspergillus niger, equal to the standard drug, ketoconazole. The molecular properties of the synthesized molecules were studied to identify druglikeness properties of the target compounds. On the basis of molecular properties prediction, 19a, 19b, 20b, 20c, 21a-c, 22b, 22c, and 23a-c can be treated as drug candidates.
通过在超声条件下,用唑基磺酰基胺与唑基氯乙酰胺反应,制备了双(唑基磺酰基)乙酰胺库。该反应在 DMAP 存在下进行得很好,导致产物的产率更高。化合物的抗菌活性表明,N-{5-[N-(2-{[4-(4-氯-1H-吡咯-2-基)-1H-咪唑-2-基)氨基]-2-氧代乙基)磺酰胺基]-4-苯基噻唑-2-基}苯甲酰胺(22a)、N- {5-[N-(2-{[4-(4-氯-1H-吡咯-2-基)-1H-咪唑-2-基]氨基}-2-氧代乙基)磺酰胺基]-4-(4-氯苯基)噻唑-2-基}苯甲酰胺(22c)和 N- {5-[N-(2-{[4-(4-氯-1H-吡咯-2-基)-1H-咪唑-2-基]氨基}-2-氧代乙基)磺酰胺基]-4-(4-氯苯基)-1H-咪唑-2-基}苯甲酰胺(24c)对枯草芽孢杆菌的最低抑菌浓度(MIC)与标准药物氯霉素相当。化合物 22c 和 24c 对黑曲霉的 MIC 也较低,与标准药物酮康唑相当。对合成分子的分子性质进行了研究,以确定目标化合物的药物性质。根据分子性质预测,19a、19b、20b、20c、21a-c、22b、22c 和 23a-c 可视为候选药物。